Search

everythinglearnresearchcommunity

for

Search:↓

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Severe acne in a young girl may indicate underlying hormonal issues.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Treatment during development affects hormone balance and sexual behavior in male rats.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.